ASCEND GENE & CELL THERAPIES
Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. They partner with biotechnology teams to embed scalable manufacturing in their operations from the beginning. They respond to customer inquiries by phone and contact form.
ASCEND GENE & CELL THERAPIES
Industry:
Biotechnology Consulting Manufacturing Therapeutics
Founded:
2021-01-01
Address:
Potters Bar, Hertford, United Kingdom
Country:
United Kingdom
Website Url:
http://www.ascend-gctx.com
Total Employee:
11+
Status:
Active
Total Funding:
132.52 M USD
Technology used in webpage:
Pound Sterling Squarespace Hosted
Similar Organizations
Biogen Diagnostica
Biogen Diagnostica is a medical device manufacturing company.
Bühler + Scherler
Bühler + Scherler is an electrical and electronic manufacturing company.
Cellular Highways
Cellular Highways provides microfluidic cell sorters for research and clinical applications.
Chemtrix
Chemtrix supplies complete and customized microreactor systems for R&D and commercial manufacturing.
MaSTherCell
MaSTherCell is an Ultimate Cell Therapy Manufacturing Partner.
Skeletal Cell Therapy Support
Skeletal Cell Therapy Support is a cell therapy manufacturing company.
Tara Biologics
Tara Biologics is a biotechnology company that discovers, develops, manufactures, and delivers biotherapeutics.
Current Employees Featured
Tim Funnell Director & Interim CEO @ Ascend Gene & Cell Therapies
Director & Interim CEO
2022-01-01
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-11-15 | Freeline Therapeutics | Freeline Therapeutics acquired by Ascend Gene & Cell Therapies | 25 M USD |
Investors List
Cathay Health
Cathay Health investment in Series A - Ascend Gene & Cell Therapies
Ajinomoto
Ajinomoto investment in Series A - Ascend Gene & Cell Therapies
Digitalis Ventures
Digitalis Ventures investment in Series A - Ascend Gene & Cell Therapies
Deerfield Capital Management
Deerfield Capital Management investment in Series A - Ascend Gene & Cell Therapies
DCVC Bio
DCVC Bio investment in Series A - Ascend Gene & Cell Therapies
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management investment in Series A - Ascend Gene & Cell Therapies
4BIO Capital
4BIO Capital investment in Series A - Ascend Gene & Cell Therapies
Abingworth
Abingworth investment in Series A - Ascend Gene & Cell Therapies
Official Site Inspections
http://www.ascend-gctx.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Ascend Gene & Cell Therapies"
Ascend Gene & Cell Therapies - Crunchbase Company Profile
Contact Email hello@ascend-gctx.com Ascend Gene & Cell Therapies supports manufacturing and process development projects from design through to clinical and commercial scales. …See details»
Ascend GCTx , North London - life-sciences-europe.com
May 14, 2023 * Document for »About Section«: Ascend Gene and Cell Therapies Ltd.. (09.05.2023). „Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend …See details»
Home | Ascend Advanced Therapies
At Ascend, we pride ourselves as a thought partner for AAV development and offer tailored services to fit every stage of your development cycle. With scientific innovation at our core, our team holds extensive experience in supporting your …See details»
Cathay Health
May 10, 2023 Visit www.ascend-gctx.com to find out more. About Cathay Health. Cathay Health, affiliated to Cathay Capital, is a global fund investing at the convergence of healthcare, life sciences and technology. As a multi-stage …See details»
ASCEND ADVANCED THERAPIES LIMITED - Companies House
More for ASCEND ADVANCED THERAPIES LIMITED (13471083) Registered office address 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT . Company status …See details»
ASCEND GENE AND CELL THERAPIES LTD · ASCEND-GCTX
ASCEND-GCTX. address: 3RD FLOOR 1 ASHLEY ROAD, ALTRINCHAM, Cheshire, GB-CHE, WA14 2DT, GB. ASCEND GENE AND CELL THERAPIES LTD (LEI# …See details»
Ascend GCTx , Central London - life-sciences-europe.com
May 14, 2023 Upcoming Events. VentureCon Bioeconomy 2025 München (Munich) Forum Labo 2025 Paris; Health Tech Hub Styria 2025 Graz; Nordic-American Healthcare Conference 2025 …See details»
Cathay Health Backed Ascend Gene & Cell Therapies
May 10, 2023 – Today, Cathay Health announces its investment in Ascend Gene & Cell Therapies (Ascend), a UK-based specialist CDMO (Contract Development & Manufacturing Organization) innovating manufacturing processes to …See details»
Ascend Gene & Cell Therapies - F6S
Ascend is a development partner that supports life-science innovators in bringing gene therapy products to patients. Our team of experts have more than 120 years of combined experience …See details»
Ascend Gene & Cell Therapies - Portfolio Company Profile, …
See Ascend Gene & Cell Therapies's complete profile, including its private equity owner and the number of its executive contacts in our database. Ascend Gene & Cell Therapies is a …See details»
Ascend Gene and Cell Therapies Company Profile -Sales, Contacts ...
Www.ascend-gctx.com: There are 9 Companies located at 1010 ATLANTIC AVE, Alameda, CA 94501 ... Research, and Management Services sector. This organization has been operating …See details»
Ascend Gene And Cell Therapies Ltd. - VentureRadar
We’re building a place for people inspired by the possibilities of biological engineering for gene & cell therapy technologies. We want to lift up a new generation of experts and breakthrough …See details»
Gene & cell therapy manufacturing specialist Ascend launches
May 9, 2023 Ascend will be attending The American Society of Gene & Cell Therapy (ASGCT) 26 th Annual Meeting in Los Angeles, CA, USA, May 16 – 20, 2023, presenting nine posters …See details»
Freeline Therapeutics–Ascend GCTx: investment, 202302 …
Feb 10, 2023 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
4BIO Capital Participates in $130M Funding of New Gene and Cell ...
London, UK, 9 May 2023 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other …See details»
Gene & cell therapy manufacturing specialist Ascend launches …
May 9, 2023 Ascend will be attending The American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, CA, USA, May 16-20, 2023, presenting nine posters …See details»
ATLAS: A High-Throughput Gain and Loss-of-Function Screening …
Ascend GCTx, Innovation Hub, 1010 Atlantic Ave.Alameda, CA, 94501 www.ascend-gctx.com Reid@ascend-gctx.com Mandegar@ascend-gctx.com ORF screen identifies hits improving …See details»
Targeted CRISPR/Cas9 Screen Identifies Superior HEK293
Ascend GCTx, Innovation Hub, 1010 Atlantic Ave.Alameda, CA, 94501 www.ascend-gctx.com Grafton@ascend-gctx.com Mandegar@ascend-gctx.com There are two dominant AAV …See details»
Gene & Cell Therapy Manufacturing Specialist Ascend Launches …
May 10, 2023 Ascend will be attending The American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, CA, USA, May 16-20, 2023, presenting nine posters …See details»
Gain and loss-of-function screens identify targets that ... - Ascend …
Www.ascend-gctx.com Reid@ascend-gctx.com Mandegar@ascend-gctx.com 1 - Ascend GCTx, Innovation Hub, 1010 Atlantic Ave.Alameda, CA, 94501 2 –Ascend GCTx GmbH | …See details»